Minute Insight: Nevro Secures Coverage For HFX Pain Therapy From Largest US Insurance Company

UnitedHealthcare will provide coverage for Nevro’s HFX spinal cord stimulation therapy for the treatment of painful diabetic neuropathy beginning on 1 March. Analysts believe the decision bodes well for the company’s chances of securing coverage from other insurers.

Minute Insight
• Source: Informa/Alamy

More from Minute Insights

More from Medtech Insight